Despite concerted efforts of healthcare agencies, haemophilia treatment coverage remains inadequate in China.
This real-world study was conducted to understand patient characteristics, clinical and economic burden, and treatment patterns amongst patients with haemophiliaÂ A in China with the aim of improving patient outcomes and quality of life.
